5.19
price up icon5.49%   0.27
 
loading
전일 마감가:
$4.92
열려 있는:
$4.8
하루 거래량:
25,689
Relative Volume:
0.13
시가총액:
$11.13M
수익:
-
순이익/손실:
$-58.52M
주가수익비율:
-2.4833
EPS:
-2.09
순현금흐름:
$-45.03M
1주 성능:
+7.68%
1개월 성능:
+1,004%
6개월 성능:
+504.90%
1년 성능:
+224.38%
1일 변동 폭
Value
$4.75
$5.20
1주일 범위
Value
$4.75
$5.37
52주 변동 폭
Value
$0.224
$5.37

Nextcure Inc Stock (NXTC) Company Profile

Name
명칭
Nextcure Inc
Name
전화
240-399-4900
Name
주소
9000 VIRGINIA MANOR ROAD, SUITE 200, BELTSVILLE, MD
Name
직원
43
Name
트위터
@nextcureinc
Name
다음 수익 날짜
2025-03-07
Name
최신 SEC 제출 서류
Name
NXTC's Discussions on Twitter

NXTC을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
NXTC
Nextcure Inc
5.19 11.13M 0 -58.52M -45.03M -2.09
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
477.53 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
575.78 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
327.52 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
570.25 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.49 29.19B 3.81B -644.79M -669.77M -6.24

Nextcure Inc Stock (NXTC) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2022-11-04 다운그레이드 Ladenburg Thalmann Buy → Neutral
2022-03-01 개시 Ladenburg Thalmann Buy
2021-03-05 업그레이드 Truist Hold → Buy
2021-01-15 다운그레이드 BofA Securities Neutral → Underperform
2020-07-16 업그레이드 The Benchmark Company Hold → Buy
2020-07-13 다운그레이드 ROTH Capital Buy → Neutral
2020-07-13 다운그레이드 SunTrust Buy → Hold
2020-06-01 다운그레이드 BofA/Merrill Buy → Neutral
2020-06-01 다운그레이드 The Benchmark Company Buy → Hold
2020-05-26 개시 JMP Securities Mkt Outperform
2020-03-24 개시 The Benchmark Company Buy
2020-03-02 개시 ROTH Capital Buy
2020-01-13 개시 SunTrust Buy
2019-12-05 개시 Needham Buy
2019-11-26 개시 BTIG Research Buy
2019-07-09 개시 BofA/Merrill Buy
2019-06-03 개시 Morgan Stanley Overweight
2019-06-03 개시 Piper Jaffray Overweight
모두보기

Nextcure Inc 주식(NXTC)의 최신 뉴스

pulisher
10:54 AM

What analysts say about NextCure Inc. stockSuperior investment outcomes - Autocar Professional

10:54 AM
pulisher
07:27 AM

NextCure Inc. Stock Analysis and ForecastFree Predictions - Autocar Professional

07:27 AM
pulisher
Jul 22, 2025

What drives NextCure Inc. stock priceExceptional return forecasts - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Is NextCure Inc. a good long term investmentHigh-octane financial growth - Autocar Professional

Jul 21, 2025
pulisher
Jul 16, 2025

What makes NextCure Inc. stock price move sharplyConsistent Growth Alert - Newser

Jul 16, 2025
pulisher
Jul 16, 2025

Why NextCure Inc. stock attracts strong analyst attentionFree Access to Community - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

How NextCure Inc. stock performs during market volatilitySecure Your Capital Strategy - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Piper Sandler lowers NextCure stock price target to $15 after reverse split By Investing.com - Investing.com South Africa

Jul 15, 2025
pulisher
Jul 15, 2025

Piper Sandler lowers NextCure stock price target to $15 after reverse split - Investing.com India

Jul 15, 2025
pulisher
Jul 14, 2025

NextCure initiates one-for-twelve reverse stock split on Nasdaq By Investing.com - Investing.com Nigeria

Jul 14, 2025
pulisher
Jul 14, 2025

NextCure Implements Reverse Stock Split on Nasdaq - TipRanks

Jul 14, 2025
pulisher
Jul 14, 2025

NextCure initiates one-for-twelve reverse stock split on Nasdaq - Investing.com

Jul 14, 2025
pulisher
Jul 10, 2025

NextCure Announces One-for-Twelve Reverse Stock Split - TipRanks

Jul 10, 2025
pulisher
Jul 10, 2025

NextCure announces 1-for-12 reverse stock split effective July 14 - Investing.com Nigeria

Jul 10, 2025
pulisher
Jul 10, 2025

NextCure announces 1-for-12 reverse stock split effective July 14 By Investing.com - Investing.com South Africa

Jul 10, 2025
pulisher
Jul 06, 2025

Analysts Offer Insights on Healthcare Companies: NextCure (NXTC), Lexaria Bioscience (LEXX) and Travere Therapeutics (TVTX) - The Globe and Mail

Jul 06, 2025
pulisher
Jul 02, 2025

NextCure’s (NXTC) Buy Rating Reaffirmed at HC Wainwright - Defense World

Jul 02, 2025
pulisher
Jun 23, 2025

Eyes on Asia: AstraZeneca, NextCure, Sagimet Biosciences - BioXconomy

Jun 23, 2025
pulisher
Jun 17, 2025

Nextcure Inc: Analyzing NXTC Stock Trends - investchronicle.com

Jun 17, 2025
pulisher
Jun 17, 2025

Market Recap: Next Technology Holding Inc (NXTT)’s Positive Momentum, Closing at 1.40 - DWinneX

Jun 17, 2025
pulisher
Jun 17, 2025

Market Highlights: Nextcure Inc (NXTC) Ends on a Low Note at 0.50 - DWinneX

Jun 17, 2025
pulisher
Jun 17, 2025

NextCure tanks as it teams up with Simcere on novel ADC - The Pharma Letter

Jun 17, 2025
pulisher
Jun 17, 2025

NextCure and Simcere partner to develop SIM0505 for solid tumours - yahoo.com

Jun 17, 2025
pulisher
Jun 16, 2025

NextCure partners with Simcere Zaiming on cancer drug development By Investing.com - Investing.com South Africa

Jun 16, 2025
pulisher
Jun 16, 2025

NextCure Joins China-ADC Gold Rush with $745M Simcere Deal - BioSpace

Jun 16, 2025
pulisher
Jun 16, 2025

NextCure Inks $745M Deal With Simcere For Cancer Drug: Retail’s More Optimistic Despite Stock’s 27% Decline - Asianet Newsable

Jun 16, 2025
pulisher
Jun 16, 2025

NextCure And Simcere Zaiming Partner To Develop CDH6-Targeting ADC SIM0505 For Solid Tumors - Nasdaq

Jun 16, 2025
pulisher
Jun 16, 2025

NextCure signs up to $745 million deal with China's Simcere to develop cancer drug - MarketScreener

Jun 16, 2025
pulisher
Jun 16, 2025

Simcere Pharmaceutical's Unit Enters Into License Agreement With Nextcure - marketscreener.com

Jun 16, 2025
pulisher
Jun 16, 2025

NextCure Enters Licensing Agreement with Simcere Zaiming - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

NextCure (NXTC) Partners with Simcere Zaiming for Innovative Cancer Treatment | NXTC Stock News - GuruFocus

Jun 16, 2025

Nextcure Inc (NXTC) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$22.87
price up icon 4.91%
$35.94
price down icon 0.47%
$102.36
price down icon 0.58%
$27.75
price up icon 4.47%
$113.94
price up icon 2.30%
biotechnology ONC
$295.76
price up icon 0.06%
자본화:     |  볼륨(24시간):